Track topics on Twitter Track topics that are important to you
Ajdovšcina, Slovenia, June 2, 2015 / B3C newswire / -- BIA Separations is proud to announce the expansion of its distribution network in China through collaboration with Guangzhou Bairui Medicine (hereinafter as Bairui).
As of 15th May, BIA Separations' analytical and preparative CIM monolith columns, including CIMac™, CIM® and CIMmultus™ will also be available to the Chinese customers through Bairui as well as services which will be performed by a joint group of experts of both companies.
Bairui is a GSP certified pharmaceutical company who is engaged in the business of manufacturing, promotiom and distribution of various pharmaceutical products in the territory of People’s Republic of China with 15 years of experience. Bairui’s multi-service approach includes:
About BIA Separations
BIA Separations is the only worldwide developer and manufacturer of CIM Convective Interaction MediaR -- short monolithic chromatographic columns optimized for the separation and purification of large bio-molecules and viral particles on the laboratory and industrial scale.
Original Article: BIA Separations Expanding its Distribution Network in ChinaNEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...